Release Therapeutics

Release Therapeutics is a Swiss bioMedTech company developing the first cell macroencapsulation technology designed to deliver potent therapeutic proteins beyond the human blood-brain barrier. Their proprietary technology integrates an implantable macroencapsulation device with an immortalised myoblast cell line capable of producing a broad range of proteins for long-term delivery to the CNS. This innovative approach aims to treat genetic diseases of the CNS without gene therapy, offering a safer and more effective alternative for patients.

Release Therapeutics is focused on treating rare and serious lysosomal storage disorders, with their lead program in Metachromatic Leukodystrophy (MLD) currently in preclinical development. They are also exploring applications for other lysosomal storage disorders, CNS malignancies, and neurodegenerative diseases. Their technology promises to revolutionize the treatment of CNS disorders by providing a new way to deliver therapeutic proteins directly to the brain, ultimately improving the lives of patients with limited treatment options.

Release Therapeutics does not currently have any open job positions advertised. The company states that they are always looking for talented and highly motivated team members and interns and applicants can send a CV and motivation letter to the company.

Release Therapeutics is a Swiss BioMedTech company committed to developing innovative treatments for genetic and severe diseases. Their mission focuses on advancing cutting-edge technology science, specifically their patented encapsulated-cell technology, to explore new therapies. They are dedicated to enhancing lives through unique CNS functionality and versatile applications, ultimately providing hope for patients with limited treatment options and their families.

Release Therapeutics promotes a culture of innovation, dedication, and solution-oriented thinking. The company values teamwork, collaboration, and a strong work ethic, while also emphasizing a positive and optimistic attitude. This is reflected in their mission statement, which emphasizes advancing cutting-edge science and exploring new treatments for genetic and severe diseases. They also highlight the importance of their team's experience and expertise, as well as their commitment to achieving the best possible outcomes for their patients.

Release Therapeutics, a Swiss BioMedTech company, actively fosters a diverse, equitable, and inclusive work environment, valuing the unique perspectives and contributions of all individuals. The company prioritizes the recruitment and retention of talent from diverse backgrounds, promoting opportunities for professional growth and leadership. Release Therapeutics encourages open communication and collaboration, creating a culture of respect, empathy, and understanding where all employees feel valued and empowered to thrive.